Dublin, Feb. 19, 2019 (GLOBE NEWSWIRE) -- The "Global Nuclear Medicine Market: Analysis By Product Type, By Diagnostic Nuclear Medicine Type, By Therapeutic Nuclear Medicine Type, By Indication, By Region, By Country (2019 Edition): Opportunities and Forecast (2013-2023)" report has been added to ResearchAndMarkets.com's offering.

Global market is projected to display a robust growth represented by a CAGR of 10.07% during 2018 - 2023.

The indication segment of Oncological disorders has been witnessing growth at a noteworthy rate over the past few years backed by increased prevalence of cancer, presence of technical advance PET and SPECT equipment to perform treatment, rising number of nuclear centers.

Amongst the regions, North America accounts for the largest regional share in the global nuclear medicine market in 2018. Key factors driving the robust growth rate of North America region include well developed healthcare infrastructure, favorable regulatory reforms, rising prevalence of chronic ailment such as cardiovascular disorders, neurological disorders etc. in the region.

The report intends to provide cutting-edge market intelligence and help decision makers take sound investment evaluation. Besides, the report also identifies and analyses the emerging trends along with major drivers, challenges and opportunities in the global nuclear medicine devices market. Additionally, the report also highlights market entry strategies for various companies across the globe.

Key Topics Covered:

1. Research Methodology

2. Executive Summary

3. Strategic Recommendations

4. Nuclear Medicine Market Overview

5. Global Nuclear Medicine: Growth and Forecast
5.1 By Value (2013-2017)
5.2 By Value (2018-2023)

6. Global Nuclear Medicine Market: By Indication
6.1 Global Nuclear Medicine Market-By Product Type: Breakdown(%)
6.1.1 Global Nuclear Medicine Market Size and Share, By Product Type, 2017
6.1.2 Global Nuclear Medicine Market Size and Share, By Product Type, 2023
6.2 Global Diagnostic Nuclear Medicine Market Overview
6.2.1 By Value (2013-2023)
6.3 Global Therapeutic Nuclear Medicine Market Overview
6.3.1 By Value (2013-2023)

7. Global Nuclear Medicine Market: By Therapeutic Type
7.1 Global Nuclear Medicine Market: By Therapeutic Type: Breakdown(%)
7.1.1 Global Nuclear Medicine Market Size and Share, Market-By Therapeutic Type, 2017
7.1.2 Global Nuclear Medicine Market Size and Share, Market-By Therapeutic Type ,2023
7.2 Global Beta Emitters Nuclear Medicine Market Overview
7.3 Global Alpha Emitters Nuclear Medicine Market Overview
7.4 Global Brachytherapy Nuclear Medicine Market Overview

8. Global Nuclear Medicine Market:By Diagnostic Type
8.1 Global Nuclear Medicine Market:By Diagnostic Type: Breakdown(%)
8.1.1 Global Nuclear Medicine Market:By Diagnostic Type, 2017
8.1.2 Global Nuclear Medicine Market:By Diagnostic Type, 2023
8.2 Global SPECT Nuclear Medicine Market Overview
8.2.1 By Value (2013-2023)
8.3 Global PET Nuclear Medicine Market Overview
8.3.1 By Value (2013-2023)

9. Global Nuclear Medicine Market:By Indication
9.1 Global Nuclear Medicine Market:By Indication: Breakdown(%)
9.1.1 Global Nuclear Medicine Market:Indication, 2017
9.1.2 Global Nuclear Medicine Market:Indication, 2023
9.2 Global Nuclear Medicine For Oncological Disorders Market
9.3 Global Nuclear Medicine For Cardiovascular Disorders Market
9.4 Global Nuclear Medicine For Neurological Disorders Market
9.5 Global Nuclear Medicine For Other Disorders Market

10. Global Nuclear Medicine Market: Regional Analysis
10.1 Global Nuclear Medicine Market, By Region: Breakdown (%)
10.1.1 Global Nuclear Medicine Market Size, By Region, 2017 (%)
10.1.2 Global Nuclear Medicine Market Size, By Region, 2023 (%)
10.2 North America Nuclear Medicine Market: An Analysis
10.3 North America Nuclear Medicine Market: Segment Analysis
10.4 North America Nuclear Medicine Market: Country Analysis (U.S. and Canada)
10.5 Europe Nuclear Medicine Market: An Analysis
10.6 Europe Nuclear Medicine Market: Segment Analysis
10.7 Europe Nuclear Medicine Market: Country Analysis (Germany, France., Rest of Europe)
10.8 Asia Pacific Nuclear Medicine Market: An Analysis
10.9 Asia Pacific Nuclear Medicine Market: Segment Analysis
10.10 Asia Pacific Nuclear Medicine Market: Country Analysis (India, China Japan & Rest of Asia Pacific)
10.11 Rest of World Nuclear Medicine Market: An Analysis
10.12 Rest of World Nuclear Medicine Market: Segment Analysis
10.13 Rest of World Nuclear Medicine Market: Country Analysis (Brazil & Others)

11. Market Dynamics
11.1 Drivers
11.2 Challenges

12. Market Trends

13. Porter's Five Forces Analysis-Nuclear Medicine Market

14. SWOT Analysis-Nuclear Medicine Market

15. Supply Chain Analysis Nuclear Medicine Market

16. Policy and Regulatory Landscape

17. Competitive Landscape

18. Company Profiles
18.1 Eckert & Ziegler
18.2 Advanced Accelerator Applications
18.3 Cardinal Health
18.4 3B Pharmaceuticals
18.5 Jubilant Life Sciences
18.6 Curium
18.7 Lantheus Holdings
18.8 Bracco Imaging

For more information about this report visit https://www.researchandmarkets.com/research/ppdwwz/global_nuclear?w=12

Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.

CONTACT: ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics: Diagnostics, Nuclear Medicine and Radiopharmacology